Creation of a Single Cell RNASeq Meta-Atlas to Define Human Liver Immune Homeostasis.
RNA-seq
immunology
immunotolerance
liver
liver homeostasis
scRNA-seq
single cell
Journal
Frontiers in immunology
ISSN: 1664-3224
Titre abrégé: Front Immunol
Pays: Switzerland
ID NLM: 101560960
Informations de publication
Date de publication:
2021
2021
Historique:
received:
12
03
2021
accepted:
28
06
2021
entrez:
2
8
2021
pubmed:
3
8
2021
medline:
30
10
2021
Statut:
epublish
Résumé
The liver is unique in both its ability to maintain immune homeostasis and in its potential for immune tolerance following solid organ transplantation. Single-cell RNA sequencing (scRNA seq) is a powerful approach to generate highly dimensional transcriptome data to understand cellular phenotypes. However, when scRNA data is produced by different groups, with different data models, different standards, and samples processed in different ways, it can be challenging to draw meaningful conclusions from the aggregated data. The goal of this study was to establish a method to combine 'human liver' scRNA seq datasets by 1) characterizing the heterogeneity between studies and 2) using the meta-atlas to define the dominant phenotypes across immune cell subpopulations in healthy human liver. Publicly available scRNA seq data generated from liver samples obtained from a combined total of 17 patients and ~32,000 cells were analyzed. Liver-specific immune cells (CD45+) were extracted from each dataset, and immune cell subpopulations (myeloid cells, NK and T cells, plasma cells, and B cells) were examined using dimensionality reduction (UMAP), differential gene expression, and ingenuity pathway analysis. All datasets co-clustered, but cell proportions differed between studies. Gene expression correlation demonstrated similarity across all studies, and canonical pathways that differed between datasets were related to cell stress and oxidative phosphorylation rather than immune-related function. Next, a meta-atlas was generated
Identifiants
pubmed: 34335581
doi: 10.3389/fimmu.2021.679521
pmc: PMC8322955
doi:
Substances chimiques
Biomarkers
0
Types de publication
Journal Article
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Pagination
679521Subventions
Organisme : NHLBI NIH HHS
ID : R01 HL144790
Pays : United States
Organisme : NHLBI NIH HHS
ID : R01 HL151493
Pays : United States
Informations de copyright
Copyright © 2021 Rocque, Barbetta, Singh, Goldbeck, Helou, Loh, Ung, Lee, Akbari and Emamaullee.
Déclaration de conflit d'intérêts
The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.
Références
Int Immunol. 2019 Apr 26;31(5):303-314
pubmed: 30721990
Nucleic Acids Res. 2002 Jan 1;30(1):207-10
pubmed: 11752295
Eur J Immunol. 2000 Feb;30(2):568-76
pubmed: 10671213
Biol Methods Protoc. 2020;5(1):bpz019
pubmed: 31984226
Cytokine Growth Factor Rev. 2019 Aug;48:24-31
pubmed: 31296363
Front Genet. 2019 Apr 05;10:317
pubmed: 31024627
Mol Chem Neuropathol. 1994 Oct-Dec;23(2-3):103-14
pubmed: 7702701
Nature. 2013 Sep 26;501(7468):506-11
pubmed: 24037378
Nat Methods. 2017 Sep 29;14(10):935-936
pubmed: 28960196
Hepatology. 2006 Feb;43(2 Suppl 1):S54-62
pubmed: 16447271
Nature. 2019 Aug;572(7768):199-204
pubmed: 31292543
Front Immunol. 2019 Jul 16;10:1582
pubmed: 31379818
Nat Methods. 2019 Oct;16(10):1007-1015
pubmed: 31501550
Nucleic Acids Res. 2010 Sep;38(17):e169
pubmed: 20660011
Cell Discov. 2020 Apr 28;6:22
pubmed: 32351704
Cells. 2017 Dec 07;6(4):
pubmed: 29215603
Genome Biol. 2020 Jun 2;21(1):130
pubmed: 32487174
Neurology. 2010 Sep 14;75(11):1009-14
pubmed: 20837969
Nat Methods. 2019 Dec;16(12):1289-1296
pubmed: 31740819
Sci Rep. 2018 Jun 25;8(1):9588
pubmed: 29942049
Sci Rep. 2017 Oct 6;7(1):12781
pubmed: 28986563
Front Immunol. 2019 Nov 05;10:2525
pubmed: 31787967
Trends Genet. 2013 Oct;29(10):569-74
pubmed: 23810203
Nat Biotechnol. 2018 Jun;36(5):411-420
pubmed: 29608179
Front Immunol. 2018 Nov 09;9:2401
pubmed: 30473690
Science. 2015 May 8;348(6235):660-5
pubmed: 25954002
Nat Commun. 2018 Oct 22;9(1):4383
pubmed: 30348985
Am J Clin Pathol. 2004 Feb;121(2):254-63
pubmed: 14983940
Cell. 2019 Jun 13;177(7):1888-1902.e21
pubmed: 31178118
N Engl J Med. 2019 Jun 6;380(23):2192-2195
pubmed: 31167049
Exp Mol Med. 2018 Aug 7;50(8):1-14
pubmed: 30089861
Genome Biol. 2019 Oct 17;20(1):210
pubmed: 31623682
Nat Rev Gastroenterol Hepatol. 2016 Feb;13(2):88-110
pubmed: 26758786